4E-BP1 |
4E-binding protein |
4HPR |
N-(4-hydroxyphenyl) retinamide |
5-AzadCyD |
5-aza-2′-deoxycytidine |
AR |
androgen receptor |
ATRA |
all-trans-retinoic acid |
AnRE |
antioxidant response element |
Bcl-2 |
B-cell lymphoma |
BRCA1/2 |
breast cancer 1/2 |
CyB |
cyclin B |
CyD1 |
cyclin D1 |
CI |
combination index |
CRPC |
castration resistant prostate cancer |
DHODH |
dihydroorotate dehydrogenase |
DNA |
deoxyribonucleic acid |
E-cad |
E-cadherin |
ERG |
ETS-related gene |
ETS |
erythroblast transformation specific |
GSK-3β |
glycogen kinase synthase-3β |
HDAC |
histone deacetylase |
HIF-1α |
hypoxia inducible factor-1α |
IC50
|
half-maximal inhibitory concentration |
IGF-1 |
insulin-like growth factor-1 |
MMP |
matrix metalloprotease |
Mnk1/2 |
mitogen-activated protein kinase interacting kinases 1 and 2 |
N-cad |
N-cadherin |
Nrf2 |
nuclear factor-erythroid 2 p45-related factor 2 |
PARP |
poly(ADP-ribose) polymerase |
PC |
prostate cancer |
PI3K |
phosphatidylinositol 3-kinase |
PPAR |
peroxisome proliferator-activated receptor |
RAMBA |
retinoid acid metabolism blocking agent |
RAR |
retinoid acid receptor |
RARE |
retinoid acid response element |
RNS |
reactive nitrogen species |
ROS |
reactive oxygen species |
RXR |
retinoid X receptor |
SAHA |
suberoylanilide hydroxamic acid |
SIRT |
sirtuin |
SOD |
superoxide dismutase |
TR |
thyroid receptor |
TR4 |
testicular nuclear receptor 4 |
VDR |
vitamin D receptor |
VEGF |
vascular endothelial growth factor |
eIF4E |
eukaryotic translation initiation factor 4E |
mTOR |
mammalian target of rapamycin |